These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 25757214

  • 21. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
    Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A.
    Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM, Uberfuhr P, Fuchs A, Schulze C, Nollert G, Mair H, Martin S, Pfeiffer M, Reichenspurner H, Kreuzer E, Reichart B.
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [Abstract] [Full Text] [Related]

  • 28. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J, Li Y, Zhang H, Wei X, Zheng H, Xu C, Bao X, Yuan X, Hou J.
    Clin Transplant; 2013 Aug; 27(4):E351-8. PubMed ID: 23682828
    [Abstract] [Full Text] [Related]

  • 29. Impact of steroid-avoidance immunosuppression on long-term outcome after liver transplantation for HCV cirrhosis: the need for well documented long-term follow-up.
    Bonaccorsi-Riani E, Sempoux C, Piette N, Julliard O, Kabamba B, Ciccarelli O, Roggen F, De Reyck C, Hassoun Z, Lerut J.
    Acta Gastroenterol Belg; 2012 Dec; 75(4):411-8. PubMed ID: 23402084
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N, Galván ME, Cáceres-Guido P, Dip M, Licciardone N, Imventarza O, Schaiquevich P, Buamscha D.
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
    [No Abstract] [Full Text] [Related]

  • 33. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 34. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A.
    Ann Transplant; 2014 Jan 22; 19():32-40. PubMed ID: 24457606
    [Abstract] [Full Text] [Related]

  • 35. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct 22; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
    Choi HJ, Kim DG, Kwak BJ, Han JH, Hong TH, You YK.
    Drug Des Devel Ther; 2018 Oct 22; 12():295-301. PubMed ID: 29483770
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
    Valdivieso N, Oteo I, Valdivieso A, Lukas JC, Leal N, Gastaca M, de Urbina JO, Calvo R, Suarez E.
    Int J Clin Pharmacol Ther; 2013 Jul 22; 51(7):606-14. PubMed ID: 23735178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.